Cepok S - Search Results

1

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.

Stüve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC. Stüve O, et al. Among authors: cepok s. Arch Neurol. 2005 Oct;62(10):1620-3. doi: 10.1001/archneur.62.10.1620. Arch Neurol. 2005. PMID: 16216948

2

New immunopathologic insights into multiple sclerosis.

Hemmer B, Kieseier B, Cepok S, Hartung HP. Hemmer B, et al. Among authors: cepok s. Curr Neurol Neurosci Rep. 2003 May;3(3):246-55. doi: 10.1007/s11910-003-0085-y. Curr Neurol Neurosci Rep. 2003. PMID: 12691630 Free PMC article. Review.

3

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, Sommer N, Hartung HP, Hemmer B. Cepok S, et al. Brain. 2005 Jul;128(Pt 7):1667-76. doi: 10.1093/brain/awh486. Epub 2005 Mar 30. Brain. 2005. PMID: 15800022

4

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.

Stüve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand'Maison F, Hemmer B, Monson NL, Racke MK. Stüve O, et al. Among authors: cepok s. Arch Neurol. 2006 Oct;63(10):1383-7. doi: 10.1001/archneur.63.10.1383. Arch Neurol. 2006. PMID: 17030653 Clinical Trial.

5

Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection.

Cepok S, von Geldern G, Nolting T, Grummel V, Srivastava R, Zhou D, Hartung HP, Adams O, Arendt G, Hemmer B. Cepok S, et al. Ann Neurol. 2007 Nov;62(5):458-67. doi: 10.1002/ana.21195. Ann Neurol. 2007. PMID: 17703460

6

Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.

Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand S, Nessler S, Rothhammer V, Lang M, Hartung HP, Hemmer B. Cepok S, et al. Arch Neurol. 2009 Oct;66(10):1216-23. doi: 10.1001/archneurol.2009.138. Epub 2009 Aug 10. Arch Neurol. 2009. PMID: 19667211

7

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

Martin Mdel P, Cravens PD, Winger R, Kieseier BC, Cepok S, Eagar TN, Zamvil SS, Weber MS, Frohman EM, Kleinschmidt-Demasters BK, Montine TJ, Hemmer B, Marra CM, Stüve O. Martin Mdel P, et al. Among authors: cepok s. Arch Neurol. 2009 Aug;66(8):1016-20. doi: 10.1001/archneurol.2009.157. Arch Neurol. 2009. PMID: 19667224

8

The role of antibodies in multiple sclerosis.

Weber MS, Hemmer B, Cepok S. Weber MS, et al. Among authors: cepok s. Biochim Biophys Acta. 2011 Feb;1812(2):239-45. doi: 10.1016/j.bbadis.2010.06.009. Epub 2010 Jun 25. Biochim Biophys Acta. 2011. PMID: 20600871 Free article. Review.

9

Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis.

Buck D, Cepok S, Hoffmann S, Grummel V, Jochim A, Berthele A, Hartung HP, Wassmuth R, Hemmer B. Buck D, et al. Among authors: cepok s. Arch Neurol. 2011 Apr;68(4):480-7. doi: 10.1001/archneurol.2011.65. Arch Neurol. 2011. PMID: 21482927

10

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients.

Jacobsen M, Cepok S, Quak E, Happel M, Gaber R, Ziegler A, Schock S, Oertel WH, Sommer N, Hemmer B. Jacobsen M, et al. Among authors: cepok s. Brain. 2002 Mar;125(Pt 3):538-50. doi: 10.1093/brain/awf059. Brain. 2002. PMID: 11872611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters